InflaRx (IFRX) Depreciation & Amortization (CF) (2017 - 2026)

InflaRx's (IFRX) quarterly Depreciation & Amortization (CF) came in at $102067.9 in Q1 2026, down 14.73% year-on-year from $119705.5 in Q1 2025, and down 3.53% quarter-over-quarter from $105798.8 in Q4 2025.

InflaRx (IFRX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

InflaRx has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $102067.9 for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $102067.9, down 14.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $454705.6 (down 10.86% YoY), and the FY2025 annual result was $488296.5, down 5.81% from the prior year.
  • Depreciation & Amortization (CF) came in at $102067.9 for Q1 2026 at InflaRx, down from $105798.8 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $172077.9 in Q1 2022 to a low of $102067.9 in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $145824.3 (2023), against an average of $137828.6.
  • Across the five-year window, Depreciation & Amortization (CF) decreased 23.6% in 2022 and increased 1.72% in 2023, its largest moves.
  • InflaRx's Depreciation & Amortization (CF) stood at $151276.2 in 2022, then dropped by 3.6% to $145824.3 in 2023, then dropped by 18.85% to $118333.0 in 2024, then decreased by 10.59% to $105798.8 in 2025, then decreased by 3.53% to $102067.9 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $102067.9 (Q1 2026), $105798.8 (Q4 2025), and $116663.5 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1,395.22
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 55.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 429,663.65
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 102,067.95

Historic Data

Download Data
DateValue
Mar 31, 2026 102,067.95
Mar 31, 2026 102,067.95
Dec 31, 2025 105,798.75
Dec 31, 2025 105,798.75
Sep 30, 2025 116,663.51
Sep 30, 2025 116,663.51
Jun 30, 2025 130,175.36
Jun 30, 2025 130,175.36
Mar 31, 2025 119,705.50
Mar 31, 2025 119,705.50
Dec 31, 2024 118,333.05
Dec 31, 2024 118,333.05
Sep 30, 2024 122,391.07
Sep 30, 2024 122,391.07
Jun 30, 2024 149,669.07
Jun 30, 2024 149,669.07
Mar 31, 2024 134,653.45
Mar 31, 2024 134,653.45
Dec 31, 2023 145,824.29
Dec 31, 2023 145,824.29